Company Filing History:
Years Active: 1980-1981
Title: Inventor Profile: Cornelis A. Ladage
Introduction
Cornelis A. Ladage is a notable inventor based in De Meern, Netherlands. He holds two patents that reflect his expertise in the pharmaceutical field, particularly in the development of solvent vehicles for therapeutic applications.
Latest Patents
Cornelis A. Ladage's latest patents involve innovative pharmaceutical compositions aimed at improving the delivery and efficacy of therapeutic materials. His first patent focuses on solvent vehicles that contain a dialkyl ester of adipic acid and, optionally, dimethyl sulfoxide (DMSO). These formulations are particularly beneficial for therapeutic materials that exhibit low solubility or are insoluble in water. The invention highlights compositions suitable for parenteral administration, especially by intramuscular injection. One embodiment addresses the treatment of diseases caused by internal parasites, specifically offering a solution against distomatosis (liver fluke disease). The injectable composition comprises a precise formulation of 12.5 grams of 4,6'-dichloro-4',6-dinitro-2,2'-methylene-diphenol, 30 grams of DMSO, and di-n-butyl adipate, completed up to 100 cm³.
Career Highlights
Cornelis A. Ladage is associated with ACF Chemiefarma N.V., a company dedicated to innovation in chemical and pharmaceutical solutions. His contributions in the field are significant, particularly in improving therapeutic delivery methods that enhance patient care.
Collaborations
Throughout his career, Cornelis has worked alongside notable colleagues, including Douwe J. Van Linge and Huibert A. Van Riessen. Their combined efforts have contributed to advancements in pharmaceutical technologies and the development of effective treatment solutions.
Conclusion
In conclusion, Cornelis A. Ladage stands out as an influential inventor in the pharmaceutical industry. His innovative patents address critical challenges in therapeutic administration, ultimately contributing to improved health outcomes. His collaborations and career at ACF Chemiefarma N.V. exemplify his commitment to advancing medical science through innovative solutions.